Evidence map›Paper›PMID 41307449›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2025

Silver Nanoparticles Templated by the M13 Phage Exhibit High Antibacterial Activity against Gram-Negative Pathogens and a Reduced Rate of Bacterial Resistance In Vitro.

Damayanti Bagchi, Aniruddha Adhikari, Katherine McCarthy, Dayeon Kang, Yueyun Chen, Irene A Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Damayanti BagchiDepartment of Chemical and Biomolecular Engineering, Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States.
Aniruddha AdhikariDepartment of Chemical and Biomolecular Engineering, Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States.
Katherine McCarthyDepartment of Chemical and Biomolecular Engineering, Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States.
Dayeon KangDepartment of Chemical and Biomolecular Engineering, Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States.
Yueyun ChenElectron Imaging Center for Nanosystems, California NanoSystems Institute, University of California, Los Angeles, California 90095, United States.ORCID 0009-0008-4325-068X
Irene A ChenDepartment of Chemical and Biomolecular Engineering, Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095, United States.ORCID 0000-0001-6040-7927

Funding

Phage-inspired engineering and evolutionR35GM148249 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Irene Ann Chen · 2023 to 2026
$1.5M
NIGMS NIH HHS R35 GM148249
6 · The paper itself

Abstract

Silver and silver nanoparticles (AgNPs) are well-known for their antibacterial properties. However, their low potency and the emergence of resistance are major barriers to the use of AgNPs in systemic therapy. Biological products can be used to reduce and cap AgNPs during synthesis from silver salts, but the structure and properties of biotemplated AgNPs are not understood well. We observed that AgNPs templated by the

Indexed as

Anti-Bacterial AgentsBacteriophage M13Drug Resistance, BacterialGram-Negative BacteriaMetal NanoparticlesSilverEscherichia coliMicrobial Sensitivity TestsPseudomonas aeruginosaVibrio choleraeAnti-Bacterial AgentsSilver

Identifiers

PMID41307449
PMCPMC12874522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.